Literature DB >> 16734849

Cystoscopy in women with recurrent urinary tract infection.

Nathan Lawrentschuk1, Jason Ooi, Anna Pang, Krishant S Naidu, Damien M Bolton.   

Abstract

OBJECTIVE: To investigate if women with recurrent urinary tract infection (UTI) warrant cystoscopy to exclude an abnormality of the lower urinary tract. This is particularly relevant given that non-invasive imaging has often been performed to exclude abnormality. Our further aims were to correlate imaging and risk factors with cystoscopic findings to determine their predictive value in finding pathology. PATIENTS AND METHODS: A database of women undergoing cystoscopy with recurrent UTI has been maintained at our institution for 10 years. We retrospectively examined this and patient records for patient demographics, and investigative and operative data.
RESULTS: A total of 118 patients (mean 55 years) having recurrent UTI (mean 4.7 infections/year) were available. There were nine patients (8%) with significant abnormalities at cystoscopy: urethral stricture (six), bladder calculus (one), bladder diverticulum (one) and colovesical fistula (one). The negative predictive value (NPV) of imaging was 99% and significant (P < 0.01). Women with no risk factors for UTI had a NPV of 93% for normal cystoscopy (P > 0.05). The positive predictive value was low for imaging and risk factors in predicting cystoscopy findings.
CONCLUSIONS: In our study, 8% of women had significant abnormalities detected during cystoscopy with most over 50 years. Women without risk factors for recurrent UTI and with normal imaging could have a cystoscopy omitted. Younger women are less likely to have pathology and this must be factored into decisions to perform cystoscopy.

Entities:  

Mesh:

Year:  2006        PMID: 16734849     DOI: 10.1111/j.1442-2042.2006.01316.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  9 in total

1.  Guidelines for the diagnosis and management of recurrent urinary tract infection in women.

Authors:  Shawn Dason; Jeyapandy T Dason; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 2.  The etiology and management of recurrent urinary tract infections in postmenopausal women.

Authors:  Carrie Jung; Linda Brubaker
Journal:  Climacteric       Date:  2019-01-09       Impact factor: 3.005

3.  Abdominal strength in voiding cystometry: a risk factor for recurrent urinary tract infections in women.

Authors:  Jesus Salinas; Miguel Virseda; Santiago Méndez; Pablo Menéndez; Manuel Esteban; Jesus Moreno
Journal:  Int Urogynecol J       Date:  2015-05-23       Impact factor: 2.894

4.  Recurrent Urinary Tract Infections Management in Women: A review.

Authors:  Ahmed Al-Badr; Ghadeer Al-Shaikh
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

5.  A Systematic Review of the (Un)known Host Immune Response Biomarkers for Predicting Recurrence of Urinary Tract Infection.

Authors:  Iva Sorić Hosman; Andrea Cvitković Roić; Lovro Lamot
Journal:  Front Med (Lausanne)       Date:  2022-07-04

6.  Case Report: Urinary Tract Infection in a Diabetic Postmenopausal Woman With Multiple Episodes of Recurrence: An Antimicrobial Susceptibility dispute.

Authors:  Farah Khalid; Rabia Bushra; Sana Ghayas; Madiha Mushtaque
Journal:  Clin Med Insights Case Rep       Date:  2022-07-21

7.  Diagnostic yield of uroendoscopy compared to ultrasonography for evaluating lower urinary tract disorders in dogs.

Authors:  Emmelyn S Hsieh; Carrie Palm; Gilad Segev; Eric G Johnson; Kaitlin Leung; Jodi L Westropp
Journal:  J Vet Intern Med       Date:  2022-08-19       Impact factor: 3.175

Review 8.  Diagnosis and management of recurrent urinary tract infections in non-pregnant women.

Authors:  Kalpana Gupta; Barbara W Trautner
Journal:  BMJ       Date:  2013-05-29

9.  Comparison of the diagnostic yield of routine versus indicated flowmetry, ultrasound and cystoscopy in women with recurrent urinary tract infections.

Authors:  Jorik J Pat; Martijn G Steffens; Lambertus P W Witte; Tom A T Marcelissen; Marco H Blanker
Journal:  Int Urogynecol J       Date:  2021-06-14       Impact factor: 1.932

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.